Taiwan FDA registration 885b459a73b4d81c8c78c50ce0d962fd

Cimosir D Gemini High Sensitivity Tube Solution

TW: 希摩西爾D雙子高敏感度品管液
Taiwan flagTaiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.;; BIOKIT S.A.·Registered Apr 13, 2022 – Apr 13, 2027Active
Registration details
Analysis ID
885b459a73b4d81c8c78c50ce0d962fd
Customs Code
DHA05603523905
Company information
Manufacturer Country
Spain;;United States
Authorized Representative
Werfen Taiwan Limited
Product details
Intended Use
For quality control of HemosIL D-Dimer HS 500 analysis on the ACL TOP Family system.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1660 Quality control materials (analytical and non-analytical)
Import Information
QMS/QSD;; 委託製造;; 輸入
Dates and status
Registration Date
Apr 13, 2022
Expiry Date
Apr 13, 2027
Companies making similar products

Top companies providing products similar to "Cimosir D Gemini High Sensitivity Tube Solution"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Cimosir D Gemini High Sensitivity Tube Solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 885b459a73b4d81c8c78c50ce0d962fd and manufactured by INSTRUMENTATION LABORATORY CO.;; BIOKIT S.A.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including INSTRUMENTATION LABORATORY CO.;; BIOKIT S.A., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations